http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011141483-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1a788a1a2a24b2e1bfedde87d681209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46a346d06c9a05a64f2c35db7ad85487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f3cb3e12fff561ac99449c6e20a0493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e6b011f44f29eda80156e4ab3438644
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
filingDate 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac0821f852dbaa2acd9c3f24b051364a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0903978e7e0ec3c7af12cd5d6f3e239
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8235d2633cee484e9aba9b555f3e95f3
publicationDate 2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011141483-A3
titleOfInvention Stable pharmaceutical formulations containing an antihistaminic
abstract This invention relates to stable solid oral pharmaceutical compositions of 8-chloro-6,11-dihydro-11-(4-piperidylidene)5H-benzo[5,6]cyclohepta[1,2-b]pyridine, also known as descarboethoxyloratadine (desloratadine or DCL) consisting of a tablet core and a filmogenic coating and their preparation methods. The stable solid oral pharmaceutical compositions of desloratadine contains less than 0.1 % by weight of total degradation impurities (measured by HPLC). Stable solid oral pharmaceutical compositions containing small particle size of desloratadine are also disclosed.
priorityDate 2010-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1728513-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008118555-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2571933-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396424

Total number of triples: 27.